1/46
A comprehensive vocabulary review of Chapter 14: Neurological Disorders, covering brain tumors, cerebrovascular accidents, traumatic brain injury, teratogens, and degenerative disorders including Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Alzheimer's disease.
Malignant Tumor
A cancerous tumor that lacks a distinct boundary, infiltrates adjacent brain tissue, and has the potential to metastasize via the bloodstream or lymphatic system.
Benign Tumor
A noncancerous tumor that is encapsulated with a distinct border and does not infiltrate surrounding tissue or metastasize, though it can still cause neurological damage through compression.
Metastasis
The spread of malignant tumor cells from their primary site of origin to distant areas of the body via the bloodstream or lymphatic system to establish secondary tumors.
Encapsulation
The structural containment of a benign tumor within a clear border or membrane, preventing the tumor cells from invading adjacent healthy neural tissue.
Compression (Brain Damage)
A pathological mechanism by which an expanding intracranial mass directly pushes against brain tissue or occludes the ventricles, causing severe tissue displacement and neurological deficit.
Infiltration (Brain Damage)
A malignant process in which tumor cells spread into and intermingle with adjacent healthy parenchyma, making surgical resection without tissue damage extremely difficult.
Glioma
A brain tumor that arises from glial cells rather than neurons, representing one of the most serious and common forms of primary brain cancer.
Meningioma
A typically benign, encapsulated intracranial tumor that originates from cells of the meninges lining the brain and spinal cord.
Stereotactic Radiosurgery
A specialized therapeutic radiation procedure that precisely targets and destroys remaining tumor cells while minimizing ionizing damage to adjacent brain structures.
Hemorrhagic Stroke
A cerebrovascular accident (CVA) caused by the sudden rupture of a cerebral blood vessel, frequently associated with chronic high blood pressure or an aneurysm.
Ischemic (Obstructive) Stroke
A cerebrovascular accident (CVA) resulting from the occlusion of an arterial blood vessel that supplies oxygen and nutrients to the brain.
Thrombus
A blood clot that forms directly along the interior wall of a blood vessel supplying the brain, which can enlarge and occlude the lumen.
Embolus
A piece of detached material (such as a blood clot, fat, or bacterial debris) that travels through the vascular tree and lodges in a smaller artery supplying the brain.
Atherosclerotic Plaque
A buildup of fatty deposits along the arterial lining that narrows the lumen, frequently obstructing vessels like the internal carotid artery and predisposing to thrombus formation.
Excitotoxicity (Ischemia-Induced)
Neuronal death during stroke caused when oxygen and glucose depletion halts Na+/K+ pumps, producing massive depolarization and excessive release of the neurotransmitter glutamate.
Constraint-Induced Movement Therapy
A rehabilitation technique following stroke that encourages motor recovery by restricting the unaffected limb, forcing the patient to use the impaired limb.
Open Head Injury
A traumatic brain injury caused by a penetrating object (such as a bullet or bone fragment) that enters the skull, directly lacerating brain tissue and blood vessels.
Closed-Head Injury
A non-penetrating traumatic brain injury caused by blunt force to the skull, inducing bruising as the brain collides with the interior cranial vault.
Coup
The contusion or initial mechanical damage to brain tissue sustained directly beneath the site where the head receives a blunt blow.
Contrecoup
The secondary brain contusion sustained when the brain recoils in the opposite direction from an impact and strikes the opposing interior wall of the skull.
Chronic Traumatic Encephalopathy (CTE)
A progressive neurodegenerative disorder caused by repetitive head trauma, characterized by memory loss, behavioral changes, and the abnormal aggregation of tau protein.
Teratogen
Any environmental factor, chemical, or substance (such as alcohol) ingested during pregnancy that impairs embryonic or fetal development and causes birth defects.
Fetal Alcohol Syndrome (FAS)
A condition caused by prenatal alcohol exposure, marked by stunted growth, distinctive facial dysmorphologies, and severe neurodevelopmental deficits.
Parkinson's Disease
A progressive motor disorder caused by the loss of dopamine-secreting neurons in the substantia nigra, manifesting as muscular rigidity, resting tremor, postural instability, and akinesia.
Nigrostriatal System
The dopaminergic pathway originating in the substantia nigra and terminating in the caudate nucleus and putamen (neostriatum), whose degeneration underlies Parkinson's disease.
Lewy Body
An abnormal circular cytoplasmic inclusion containing a dense core of aggregated α-synuclein protein, found inside degenerating neurons in Parkinson's disease.

α-Synuclein
A protein normally located at the presynaptic membrane that participates in synaptic plasticity; its misfolding and accumulation form toxic aggregates in Parkinson's disease.
Parkin
A protein coded on chromosome 6 that normally tags misfolded proteins with ubiquitin for proteasomal destruction; its loss of function causes toxic protein accumulation.
L-DOPA
A metabolic precursor of dopamine that crosses the blood-brain barrier to increase dopamine synthesis, serving as a primary first-line pharmacotherapy for Parkinson's disease.
Deprenyl
A medication that prevents the enzymatic deactivation of dopamine, prolonging dopamine activity in the treatment of Parkinson's disease.
Deep Brain Stimulation (DBS)
A surgical procedure involving the implantation of electrodes to electrically stimulate basal ganglia targets (such as the subthalamic nucleus) to suppress motor symptoms.
Huntington's Disease
A fatal, autosomal dominant hereditary disorder causing progressive degeneration of the basal ganglia, leading to uncontrollable choreiform movements and cognitive decline.
Huntingtin (Htt)
An abnormal elongated protein encoded by a mutated dominant gene on chromosome 4 that accumulates and triggers apoptosis in striatal neurons in Huntington's disease.
Amyotrophic Lateral Sclerosis (ALS)
A progressive, fatal neurodegenerative disease that targets motor neurons of the spinal cord and cranial nerves, causing muscle spasticity, atrophy, and eventual paralysis.
Superoxide Dismutase 1 (SOD1)
An enzyme encoded by a gene on chromosome 21 whose mutation produces a toxic gain of function linked to familial amyotrophic lateral sclerosis.
Riluzole
A pharmacological treatment for amyotrophic lateral sclerosis that decreases glutamate-mediated excitotoxicity by modulating glutamate release and reuptake.
Multiple Sclerosis (MS)
An autoimmune central nervous system disorder characterized by immune-mediated demyelination of axons, leaving patches of sclerotic tissue that interrupt neural signaling.
Sclerotic Plaques
Hard patches of scar tissue and debris that replace destroyed myelin sheaths within the central nervous system white matter in multiple sclerosis.

Interferon β
A biological protein therapy that modulates immune responsiveness to reduce the relapse rate in relapsing-remitting multiple sclerosis.
Dementia
A generalized clinical syndrome marked by progressive loss of intellectual and cognitive abilities—such as memory, perception, language, and judgment.
Alzheimer's Disease
A progressive neurodegenerative disorder of the brain characterized by widespread cortical and hippocampal atrophy, memory deficits, and motor dysfunction.
Amyloid Plaque
An extracellular structural lesion characteristic of Alzheimer's disease composed of a dense core of β-amyloid protein surrounded by degenerating neural processes.

Neurofibrillary Tangle
An intracellular bundle of twisted protein filaments composed of abnormal, hyperphosphorylated tau protein, observed in the dying neurons of Alzheimer's patients.
Amyloid Precursor Protein (APP)
A transmembrane protein that can be sequentially cleaved by β-secretase and γ-secretase to yield neurotoxic β-amyloid peptides.

β-Amyloid Protein (Aβ)
A peptide fragment derived from the proteolytic cleavage of APP that misfolds, aggregates into oligomers, and forms neurotoxic plaques in Alzheimer's disease.
Apolipoprotein E (ApoE)
A lipid-binding glycoprotein whose genetic allele variants significantly alter the susceptibility and onset risk of late-onset Alzheimer's disease.
Acetylcholinesterase Inhibitor
A medication class used to alleviate cognitive symptoms in Alzheimer's disease by retarding acetylcholine breakdown, thereby enhancing cholinergic transmission.